| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.25 | 3e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.24 | 5e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 1e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.24 | 2e-05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |